Gene Therapy

Gene Therapy includes companies delivering genetic material to correct, replace, silence, or modulate disease-driving biology. This sector page is useful for following businesses exposed to AAV, lentiviral, non-viral, or editing-enabled approaches across rare and broader diseases.

Why watch Gene Therapy

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Gene Therapy news

The latest feed items from companies currently grouped under Gene Therapy.

1. 01
   2026-09-04 20:05 EST

   NTLAIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   Source: Intellia

2. 02
   2026-09-04 12:50 EST

   NTLAIntellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million

   Source: Intellia

3. 03
   2026-09-04 12:00 EST

   TSHATaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

   Source: Taysha Gene Therapies

4. 04
   2026-09-04 12:00 EST

   NTLAIntellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference

   Source: Intellia

5. 05
   2026-09-03 12:00 EST

   KRYSKrystal Biotech to Present at 2026 Cantor Global Healthcare Conference

   Source: Krystal Biotech

6. 06
   2026-09-03 11:00 EST

   RCKTRocket Pharmaceuticals to Participate in Upcoming Investor Conferences

   Source: Rocket Pharmaceuticals

7. 07
   2026-09-02 11:30 EST

   ABEOAbeona Therapeutics® Announces Participation in Upcoming Investor Conferences

   Source: Abeona Therapeutics

8. 08
   2026-09-01 20:05 EST

   SANASana Biotechnology to Present at September 2026 Investor Conferences

   Source: Sana Biotechnology

9. 09
   2026-09-01 13:00 EST

   EDITEditas Medicine to Participate in Upcoming Investor Conferences

   Source: Editas Medicine

10. 10
    2026-09-01 12:00 EST

    VYGRVoyager to Present at Upcoming Investor Conferences

    Source: Voyager Therapeutics

11. 11
    2026-09-01 11:30 EST

    ABEOAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Abeona Therapeutics

12. 12
    2026-09-01 11:02 EST

    OCGNOcugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

    Source: Ocugen

13. 13
    2026-09-01 07:00 EST

    GSKGSK to advance mRNA seasonal flu vaccine candidate to phase III following positive phase II data

    Source: GSK plc

14. 14
    2026-08-31 20:30 EST

    SRPTSarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

    Source: Sarepta Therapeutics

15. 15
    2026-08-28 14:31 EST

    CRSPCRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026

    Source: CRISPR Therapeutics

16. 16
    2026-08-25 11:02 EST

    OCGNOcugen to Participate in Upcoming September Investor and Industry Conferences

    Source: Ocugen

17. 17
    2026-08-24 07:01 EST

    GSKJemperli (dostarlimab) accepted for priority review by the US FDA for dMMR/MSI-H locally advanced rectal cancer

    Source: GSK plc

18. 18
    2026-08-24 07:00 EST

    GSKHibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B

    Source: GSK plc

19. 19
    2026-08-19 12:05 EST

    MXCTMaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies

    Source: MaxCyte

20. 20
    2026-08-13 20:05 EST

    CRBUCaribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

    Source: Caribou

Companies in Gene Therapy

38 companies tagged with Gene Therapy.

Frequently Asked Questions